Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Ian C. Mortimer$3.1B
Market Cap • 15/04/20241996
(há 28 anos)
2014
(10 years ago)
NASDAQ
Listagem
Burnaby
Sede • BC213
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
XENESó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.